No items found.


Pemetrexed is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications.  Currently there is no marketed generic version for this product in the United States, and the brand generates annual revenues of over $1 billion USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.

Market Authorization in:
United States, Belgium, Czech Republic, Germany, Ireland, Luxembourg, Netherlands, Poland, Slovakia, Slovenia, Spain, United Kingdom
100mg, 500mg

Questions about this product?

We're here to help!

send a message